Seamus Fernandez Profile - Guggenheim Analyst
802 Followers
Seamus Fernandez's Stock Coverage
| SEPNSepterna, Inc. | Nov 06, 2026 | BUY | Assigned | $65.00 | 4Ratings | +4.32% | ||
| RYTMRhythm Pharmaceuticals | Nov 04, 2026 | BUY | Reiterated | $147.00 | 17Ratings | +28.17% | ||
| RTSNRetension Pharmaceuticals Inc | Nov 02, 2026 | BUY | Initiated | $55.00 | 1Ratings | +8.40% | ||
| BMYBristol-Myers Squibb | Oct 29, 2026 | BUY | Reiterated | $75.00 | 52Ratings | +4.74% | ||
| KYMRKymera Therapeutics | Oct 28, 2026 | BUY | Reiterated | $170.00 | 1Ratings | +3.80% | ||
| ACRSAclaris Therapeutics | Oct 28, 2026 | BUY | Reiterated | $12.00 | 5Ratings | -17.95% | ||
| ARQTArcutis Biotherapeutics | Oct 19, 2026 | BUY | Assigned | $44.00 | 16Ratings | +21.74% | ||
| PCVXVaxcyte | Oct 18, 2026 | BUY | Reiterated | $125.00 | 16Ratings | +28.66% | ||
| MBXMBX Biosciences, Inc. | Oct 12, 2026 | BUY | Reiterated | $150.00 | 17Ratings | +94.72% | ||
| SGMTSagimet Biosciences, Inc. Class A | Oct 01, 2026 | BUY | Reiterated | $26.00 | 6Ratings | +43.40% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Seamus Fernandez activity FAQ
What is the performance of Seamus Fernandez's recommendations?
The percentage of profitable recommendations made by Seamus Fernandez is 64.15%, and the average return per transaction is 28.70%.
What stocks does Seamus Fernandez cover?
Seamus Fernandez mostly covers Septerna, Inc., Rhythm Pharmaceuticals, Retension Pharmaceuticals Inc stocks.
What was Seamus Fernandez's most profitable rating?
Seamus Fernandez’s most profitable rating was a buy on CDTX stock on May 09, 2025. The return on the trade was 800.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here